A new treatment for hot flashes brought relief and a better night’s rest for women experiencing these disruptive symptoms during menopause.
Two phase 3 clinical trials compared the drug elinzanetant with a placebo at two timepoints. The drug subdued hot flashes quickly: By the fourth week, a majority of those taking the drug reported at least a 50 percent reduction in frequency.
By week 12, more than 70 percent taking elinzanetant, compared with more than 40 percent on placebo, experienced that drop in hot flash frequency, researchers reported August 22 in the Journal of the American Medical Association. Participants on elinzanetant also reported significantly improved sleep compared with those
→ Continue reading at Science News